AMBEV S.A. — Form 6-K Summary
Business context and reporting period
Filed October 9, 2026, for the month of October. The filing reports consolidated transactions in Ambev securities by directors, management, and the fiscal council from September 1–30, 2026, under CVM Instruction 44/2021. Ambev reports under Form 20-F.
Transactions and reported balances
| Group | Opening common shares | Reported September transactions | Closing common shares |
|---|---|---|---|
| Board of Directors | 30,679,627 | None reported | 30,679,627 |
| Management | 3,087,593 | Sales totaling 60,757 shares; return of 874 lent shares | 3,027,710 |
| Fiscal Council | 2,500 | None reported | 2,500 |
Management sales were 2 shares at R$15.75, 60,700 at R$15.76, and 55 at R$15.82, for reported sale proceeds of R$957,533.60. The 874-share return of lent securities was reported at R$15.31, with a stated volume of R$13,380.94. Management’s reported ADR balance was zero at both the beginning and end of the month; the filing states that each ADR represents one share.
Financial performance and material changes
This filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating and financial results. Management’s common-share balance declined by 59,883 shares net during the month; the directors’ and fiscal council’s reported balances were unchanged.
Outlook, risks, and contingencies
No guidance, outlook, management commentary, risks, or contingencies are discussed. The filing is limited to securities transactions and balances.
Important facts for investors to verify
- Confirm the reported management sales, share-lending return, prices, and volumes against the underlying transaction records.
- Confirm the group classifications and opening and closing holdings; the filing presents consolidated, not individual, balances.
- Do not treat this filing as an update on Ambev’s operating or financial performance; it contains no such metrics.